Skip to main content
. 2024 Nov 20;25:413. doi: 10.1186/s12931-024-03034-3

Table 1.

GWAS summary datasets used in this study

Explore or Outcome GWAS ID Source Population Sample size Case Control
Asthma ebi-a-GCST90014325 Valette K et al. European 408,442 56,167 352,255
Asthma (only as main-diagnosis) finngen_R10_J10_ASTHMA_MAIN_EXMORE FinnGen European 257,494 37,760 219,734
Bronchiectasis finngen_R10_J10_BRONCHIECTASIS FinnGen European 340,675 2,372 338,303
Bronchiectasis ukb-saige-496.3 Taliun D et al. European 377,387 1,882 375,505
Epistaxis ukb-b-11412 MRC-IEU European 463,010 1,512 461,498
Nasal polyp finngen_R10_J10_NASALPOLYP FinnGen European 315,298 6,841 308,457
Ear-nose-throat disorder ebi-a-GCST90038669 Dönertaş HM et al. European 484,598 17,317 467,281
Allergic rhinitis finngen_R10_ALLERG_RHINITIS FinnGen European 404,309 12,240 392,069
Acute sinusitis finngen_R10_J10_SINUSITIS FinnGen European 357,879 22,847 335,032
Chronic sinusitis finngen_R10_J10_CHRONSINUSITIS FinnGen European 326,444 17,987 308,457
Acute pharyngitis finngen_R10_J10_PHARYNGITIS FinnGen European 340,327 5,295 335,032
Chronic rhinitis, nasopharyngitis and pharyngitis finngen_R10_J10_CHRONRHINITIS FinnGen European 320,425 11,968 308,457
Eosinophill count ebi-a-GCST90013985 Mbatchou J et al. European 395,949 N/A N/A
Neutrophill count ebi-a-GCST90013984 Mbatchou J et al. European 395,949 N/A N/A